Strategic use of patents by an entrepreneurial multinational organisation in Indian context Online publication date: Mon, 05-Aug-2019
by Sutopa Roy Lahiry; Krishnamachari Rangarajan
J. for Global Business Advancement (JGBA), Vol. 12, No. 3, 2019
Abstract: This study analyses the use of patents by an Indian biotechnology entrepreneurial company which has taken a strategic and long-term view of patenting. It evaluates the journey of Biocon as an entrepreneurial organisation and analyses how the company uses patents as a strategic lever. After analysing the core competencies an analysis of the company's patent portfolio is done. Further, the strategic moves taken by the company, to generate its Intellectual Property (IP) wealth from its extensive research and development (R&D), to enable it to move up the drug discovery and development value chain are discussed (example of insulin manufacturing). It is further examined how the patents can be used, for targeting a product line and to obtain and sustainable competitive advantage. Finally, with the example of Biocon, the study elaborates on how the patents can be used as a strategic lever in the natural cycle of an entrepreneurial multinational enterprise.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the J. for Global Business Advancement (JGBA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook